Nuveen Asset Management, LLC Nurix Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $329 Billion
- Q1 2024
A detailed history of Nuveen Asset Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 418,823 shares of NRIX stock, worth $8.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
418,823
Previous 533,865
21.55%
Holding current value
$8.15 Million
Previous $5.51 Million
11.74%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding NRIX
# of Institutions
144Shares Held
50.3MCall Options Held
30.3KPut Options Held
22.7K-
Black Rock Inc. New York, NY4.58MShares$89.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.48MShares$87.3 Million2.6% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$75.6 Million0.72% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$58.4 Million1.46% of portfolio
-
State Street Corp Boston, MA2.73MShares$53.1 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $918M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...